A letter to the New England Journal of Medicine details two dramatic, but potentially cautionary tales about Tysabri. A 46-year-old woman with MS received her first dose of Tysabri; thereafter her melanoma spreads like wildfire. A 45-year-old woman with MS developed melanoma in her retina after receiving several doses of Tysabri.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments